SuperDerivatives sees more growth from buy-side sector

It is the latest in a number of sales to corporate treasuries in the past few months. Other new clients include IBM, Alcatel and Caterpillar.

“We have already achieved a fantastic take-up with the banking sector,” said David Gershon, chief executive of London-based SuperDerivatives. “Now, our success with buy-side corporations is outpacing even our most optimistic expectations.” The company’s banking clients include JP Morgan Chase, Merrill Lynch and Citigroup.

CCA treasury executive Steve Barraclough said SuperDerivatives helps the company to hedge the risk from its production and bottling activities across the region more efficiently.

“We can now access true market prices," said Barraclough. "This is extremely important as it means we are able to mark-to-market our hedging portfolio with independent rates.”

Barraclough said he heard about the system from a friend who works as an interdealer broker in London. “SuperDerivatives is extremely accurate and it gives me independence," he said. "It is much easier to use than other systems and the way it’s available on the internet makes it very appealing.”

CCA is a leading supplier of carbonated drinks in Australia, New Zealand, Fiji, Papua New Guinea, South Korea and Indonesia.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Next-generation technologies and the future of trading

At a Risk.net webinar in association with capital markets technology provider Numerix, panellists discuss the potential for increased adoption of the public cloud to boost investment performance, its impact on risk management and overcoming barriers to…

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here